FDA Announces Proposed Study on Labeling for Human Drug Products

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act of 1995, focusing on an experimental study to evaluate alternative labeling statements for prescription and over-the-counter (OTC) human drug products.